Simplify Asset Management’s Summit Therapeutics SMMT Stock Holding History

Simplify Asset Management’s Portfolio SMMT Stock Details SMMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.63M	Buy	+510,106	New	+$7.63M	0.14%	34

Other funds holding SMMT

Griffin Asset Management New York $934M AUM 18.69% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Wealth Management Partners Tucson, Arizona $426M AUM 43.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return

Simplify Asset Management's SMMT Position: Q3 2026 in Review

Simplify Asset Management opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 510,106 shares worth $8.63M. The stake represents 0.14% of the portfolio and ranks #34 among its holdings.

51 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

Simplify Asset Management held 510,106 shares of Summit Therapeutics worth $8.63M as of Q3 2026.
Summit Therapeutics was a new Simplify Asset Management position in Q3 2026.
Summit Therapeutics made up 0.14% of Simplify Asset Management's portfolio in Q3 2026, its #34 holding.
51 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Simplify Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.